miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 10, 2025

Stock market today: Dow, S&P 500 edge higher, Nasdaq wavers as Fed cuts interest rates by 25 basis points

View original at finance.yahoo.com
Stock market today: Dow, S&P 500 edge higher, Nasdaq wavers as Fed cuts interest rates by 25 basis points US stocks tipped mostly into the green on Wednesday after the Federal Reserve cut rates by 25 basis points in its final policy decision of the year…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • If gold demand continues to grow at roughly 14% (average rate since 2001), gold is likely to crack $5,000 per ounce in 2026

    80% confidence
  • Gold is overbought but underinvested with more room to grow

    80% confidence
  • We're well-positioned to see how the economy evolves

    80% confidence
  • Fed projects one more rate cut for 2026

    80% confidence
  • Central banks hold more gold than US Treasurys for the first time since at least the 1990s

    80% confidence
  • As of late, the view has been that CHWY's gross margin has limited upside going forward. While the scaling of its sponsored ad initiative has been a meaningful gross margin driver of the past several quarters, we think this trend needs to continue for the company to see the same magnitude of GM gains.

    80% confidence
  • I think it's a bit of a relief given that it could have been even more hawkish. Markets are also taking this with a grain of salt, knowing that next year we're going to get a lot of changes when it comes to the Fed.

    80% confidence
  • Gold bull markets don't normally come to an end because they're overbought. The gold markets normally come to an end because the underlying conditions that triggered a bull market have subsided, but we don't see that.

    80% confidence
  • Fed signaled a pause for January, indicating a substantial amount of data will be coming in next week, clearing up uncertainty

    80% confidence
  • China must fix economic imbalances as trade surplus hits $1T

    80% confidence
  • Chewy continues to outperform the pet category and expand market share, with profits once again growing faster than sales

    80% confidence
  • Ongoing supply disruptions and the repositioning of copper to the U.S. ahead of potential policy changes are impacting an already tight copper market. The premium paid for the metal in the U.S. is impacting already low global inventories and is placing upward pressure on global copper prices.

    80% confidence

Data points we hold from this source

Board of Governors of the Federal Reserve System · benchmark interest rate3.5-3.75 percent

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com
Stock market today: Dow, S&P 500 edge higher, Nasdaq wavers as Fed cuts interest rates by 25 basis points — Source | Via News | es.VIA.NEWS